Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts
Duchenne muscular dystrophy (DMD) affects myofibers and muscle stem cells, causing progressive muscle degeneration and repair defects. It was unknown whether dystrophic myoblasts—the effector cells of muscle growth and regeneration—are affected. Using transcriptomic, genome-scale metabolic modelling...
Main Authors: | Maxime RF Gosselin, Virginie Mournetas, Malgorzata Borczyk, Suraj Verma, Annalisa Occhipinti, Justyna Róg, Lukasz Bozycki, Michal Korostynski, Samuel C Robson, Claudio Angione, Christian Pinset, Dariusz C Gorecki |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2022-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/75521 |
Similar Items
-
PGC‐1α overexpression increases transcription factor EB nuclear localization and lysosome abundance in dystrophin‐deficient skeletal muscle
by: Hannah R. Spaulding, et al.
Published: (2020-02-01) -
Human Dystrophin Dp71ab Enhances the Proliferation of Myoblasts Across Species But Not Human Nonmyoblast Cells
by: Manal Farea, et al.
Published: (2022-04-01) -
Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients
by: Nancy Alnassar, et al.
Published: (2023-02-01) -
l-arginine improves dystrophic phenotype in mdx mice
by: Vincent Voisin, et al.
Published: (2005-10-01) -
Indicators of increased ER stress and UPR in aged D2-mdx and human dystrophic skeletal muscles
by: Swathy Krishna, et al.
Published: (2023-04-01)